Compare GOGO & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GOGO | ACB |
|---|---|---|
| Founded | 1991 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.6M | 232.3M |
| IPO Year | 2011 | 2016 |
| Metric | GOGO | ACB |
|---|---|---|
| Price | $3.61 | $5.06 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $8.50 | $4.89 |
| AVG Volume (30 Days) | ★ 2.9M | 1.6M |
| Earning Date | 11-06-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $910,491,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.11 | $10.78 |
| P/E Ratio | $59.25 | ★ N/A |
| Revenue Growth | ★ 104.74 | N/A |
| 52 Week Low | $1.96 | $2.56 |
| 52 Week High | $7.76 | $6.36 |
| Indicator | GOGO | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 68.18 | 69.04 |
| Support Level | $3.24 | $3.78 |
| Resistance Level | $3.90 | N/A |
| Average True Range (ATR) | 0.34 | 0.18 |
| MACD | 0.17 | 0.09 |
| Stochastic Oscillator | 72.32 | 83.22 |
Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services, and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped. Geographically, it operates in United States; and International as well.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.